NRCME DOT Examiner Test Practice Questions and Answers 2023

NRCME DOT Examiner Test Practice Questions and Answers 2023 According to FMCSA regulations, which of the following must the medical examiner evaluate when examining a driver's eyes? A. Pupil reactivity B. Iris symmetry C. Conjunctival injection D. Corneal thickness Correct Answer: Correct Response: A. Pupil reactivity Incorrect Responses: B. Iris symmetry This is incorrect because determining iris symmetry is not required by FMCSA. C. Conjunctival injection This is incorrect because most causes of conjunctival injection would not be disqualifying. Causes that are suspicious for a disqualifying condition need additional evaluation. While this abnormal finding should be explained, with determination of possible effects on safe driving before making a certification decision, it is not a condition that is specified in FMCSA regulations. D. Corneal thickness This is incorrect because it is not measured in an office examination except by an eye specialist. According to FMCSA regulations, medical qualification for two years can be given to a driver who has... ? A. An SPE certificate for a left below the knee amputation (BKA). B. Hypertension. C. A recent diagnosis of Lewy body dementia. D. Documented medical marijuana use for pain control. Correct Answer: Correct Response: A. An SPE certificate for a left below the knee amputation.This is the correct response because in order to obtain the SPE certificate, the driver had to demonstrate the ability to perform all tasks for the commercial driver job description. Incorrect Responses: B. Hypertension. This is not the correct response because drivers with hypertension are only given a medical certificate that is good for one year. C. A recent diagnosis of Lewy body dementia. This is not the correct response because this is a progressive, degenerative condition with no known treatment. The effects of Lewy body dementia impact the ability to operate a CMV safely. D. Documented medical marijuana use for pain control. This is not the correct response because marijuana remains a drug listed in Schedule I of the Controlled Substances Act. It remains unacceptable for any safety-sensitive employee subject to drug testing under the drug testing regulations of DOT to use marijuana. Also, FMCSA medical guidelines state that "driving impairment due to marijuana use is well substantiated."